Antiviral activity of Glucosylceramide synthase inhibitors against viral infections - 17th Nov 2021

Understanding pathways that might impact viral disease outcomes is necessary for better disease management and therapeutic development. Here, Einat Vitner of the Institute for Biological Research, Israel discusses the interplay between viruses and host sphingolipid metabolism, and the potential for targeting the sphingolipid network to prevent viral infection.